|
HY-100166-25mg
|
MedChemexpress LLC
|
AP521 [CAS 151227-08-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100166-5mg
|
MedChemexpress LLC
|
AP521 [CAS 151227-08-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100166-50mg
|
MedChemexpress LLC
|
AP521 [CAS 151227-08-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100181-10mg
|
MedChemexpress LLC
|
PF-04991532 [CAS 1215197-37-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100181-100mg
|
MedChemexpress LLC
|
PF-04991532 [CAS 1215197-37-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100181-25mg
|
MedChemexpress LLC
|
PF-04991532 [CAS 1215197-37-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100181-5mg
|
MedChemexpress LLC
|
PF-04991532 [CAS 1215197-37-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100181-50mg
|
MedChemexpress LLC
|
PF-04991532 [CAS 1215197-37-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100182-1mg
|
MedChemexpress LLC
|
BACE1-IN-1 [CAS 1310347-50-2]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-100182-10mg
|
MedChemexpress LLC
|
BACE1-IN-1 [CAS 1310347-50-2]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-100182-100mg
|
MedChemexpress LLC
|
BACE1-IN-1 [CAS 1310347-50-2]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-100182-25mg
|
MedChemexpress LLC
|
BACE1-IN-1 [CAS 1310347-50-2]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-100182-5mg
|
MedChemexpress LLC
|
BACE1-IN-1 [CAS 1310347-50-2]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-100182-50mg
|
MedChemexpress LLC
|
BACE1-IN-1 [CAS 1310347-50-2]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-100183-10mg
|
MedChemexpress LLC
|
GSK2239633A [CAS 1240516-71-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-100183-100mg
|
MedChemexpress LLC
|
GSK2239633A [CAS 1240516-71-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-100183-25mg
|
MedChemexpress LLC
|
GSK2239633A [CAS 1240516-71-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-100183-5mg
|
MedChemexpress LLC
|
GSK2239633A [CAS 1240516-71-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-100183-50mg
|
MedChemexpress LLC
|
GSK2239633A [CAS 1240516-71-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-100195-10mg
|
MedChemexpress LLC
|
SAR-020106 [CAS 1184843-57-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100195-25mg
|
MedChemexpress LLC
|
SAR-020106 [CAS 1184843-57-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100195-5mg
|
MedChemexpress LLC
|
SAR-020106 [CAS 1184843-57-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100195-50mg
|
MedChemexpress LLC
|
SAR-020106 [CAS 1184843-57-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100208-10mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
|
HY-100208-100mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
